Cue Biopharma
39 hedge funds and large institutions have $37.4M invested in Cue Biopharma in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 1 closing their positions.
Holders
39
Holders Change
+10
Holders Change %
+34.48%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
19
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$10.5M |
| 2 |
NCM
2
Nantahala Capital Management
New Canaan,
Connecticut
|
$5.02M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$7.93M |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$2.14M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$2.58M |
